![]() | ![]() |
Formats:
|
||||||||||||
Maintenance of undifferentiated mouse embryonic stem cells in suspension by the serum- and feeder-free defined culture condition 1Department of Tissue and Organ Development Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Gifu City, Gifu 501-1194, Japan 2Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, 333 Cassell Drive, Suite 3000, Baltimore, MD 21224, USA Corresponding Author: Takahiro Kunisada, Ph.D. Gifu University School of Medicine, Gifu City, Gifu 501-1194, Japan. Telephone:+81-58-230-5477; Fax: +81-58-230-6478; e-mail: tkunisad/at/gifu-u.ac.jp 3These authors contributed equally to this work. The publisher's final edited version of this article is available free at Dev Dyn. This article has been corrected. See the correction in volume 238 on page 501.Abstract The proven pluripotency of ES cells is expected to allow their therapeutic use for regenerative medicine. We present here a novel suspension culture method that facilitates the proliferation of pluripotent ES cells without feeder cells. The culture medium contains polyvinyl alcohol (PVA), free of either animal-derived or synthetic serum, and contains very low amounts of peptidic or proteinaceous materials, which are favorable for therapeutic use. ES cells showed sustained proliferation in the suspension culture, and their undifferentiated state and pluripotency were experimentally verified. DNA microarray analyses showed a close relationship between the elevated expression of genes related to cell adhesions. We suggest that this suspension culture condition provides a better alternative to the conventional attached cell culture condition, especially for possible therapeutic use, by limiting the exposure of ES cells to feeder cells and animal products. Keywords: Embryonic stem cell, Suspension culture, Serum-free, Feeder-free, Cell adhesion molecules INTRODUCTION Embryonic stem (ES) cells are pluripotent in that they can differentiate into cells of all 3 germ layers, and they also self-renew extensively in culture [Smith et al., 2001; Evans et al., 1981; Martin et al., 1981]. Therefore, their therapeutic potential in regenerative medicine has been suggesteed [Donovan et al., 2001; Prelle et al., 2002]. ES cells are derived from the inner, clonogenicity, a normal karyotype, extencell mass (ICM) of mammalian blastocysts [Evans et al., 1981; Martin et al., 1981; Thomson et al., 1998]. The basic characteristics of ES cells, which include self-renewal, multilineage differentiation, clonogenicity, a normal karyotype, extensive proliferation, and the ability to be frozen and thawed, are all the fundamental properties of early embryonic cells [Smith et al., 2001]. External signaling pathways such as LIF-gp130-STAT3 [Niwa et al., 1998; Matsuda et al., 1999; Raz et al., 1999], BMP-TGF-β -Nodal -Smad [Ying et al., 2003; Ogawa et al., 2007], MAPK-ERK [Burdon et al., 1999], and WNT [Hao et al., 2006; Ogawa et al., 2006] as well as transcription factors Oct3/4 [Niwa et al., 2000], Sox2 [Masui et al., 2007], and Nanog [Mitsui et al., 2003; Chambers et al., 2003] have been reported to play important roles in the self-renewal of mouse ES cells. The interaction of transcription factors including Oct3/4, Sox2 and Nanog seems to form a flexible interactive network to ensure the pluripotency of ES cells [Wang et al., 2006; Ivanova et al.,2006]. Epigenetic modification of the chromatin21 and global control of gene expression [Boyer et al.,2006] are also proposed to regulate their pluripotency to allow the transition from the undifferentiated to the differentiated state [Niwa et al., 2000]. Pluripotent mouse ES cells are usually propagated under complex culture conditions that are poorly defined because they include both growth-inactivated feeder cells and serum. The exposure of ES cells to these components has been a major concern for the potential therapeutic use of ES cells because of their immunogenicity and potential pathogenicity. After the discovery of LIF as a crucial factor produced by the feeder cells, mouse ES cells have been propagated in medium containing serum and LIF without feeder cells on gelatin-coated dishes. Although animal-derived serum was later substituted by synthetic serum [Goldsborough et al., 1988;Ward et al., 2002], synthetic serum products still contain considerable amounts of purified animal-derived proteins. Using ES cells expressing exogenously induced Bcl2, Yamane et al. cultured them in medium containing LIF, insulin, and transferrin as the only peptidic ingredients; and they replaced the abundantly used animal protein albumin with polyvinyl alcohol (PVA) [Yamane et al., 2005]. Still, gelatin-coated dishes were required even in this culture system, and normal ES cell strains could not be maintained for long term under this culture condition using PVA. Remarkable progress on the culture of human ES cells has recently enabled nearly completely defined culture conditions involving the least amount of mitogenic polypeptides; however, a large amount of serum albumin was added, and 4 different matrix proteins were used for coating the culture dish surface [Ludwig et al., 2006]. We describe here a new suspension culture method to propagate pluripotent mouse ES cells of different origins. This method uses culture medium adapted from Yamane et al. [Yamane et al., 2005], which includes the least amount of peptidic materials, and does not require protein-coated dishes. Long-term maintenance of the undifferentiated state and pluripotency of the suspended ES cells were confirmed in several ways. The indispensable function of PVA to maintain sphere-like assembly of ES cells in suspension culture was also indicated. We further obtained data from DNA micro array analysis suggesting roles of cell adhesion molecules for the proliferation of pluripotent ES cells under these rather stringent suspension culture conditions. RESULTS Proliferation of ES cells in suspension cultures Yamane et al. previously reported that ES cells exogenously expressing Bcl2 could be maintained in an undifferentiated state in considerably stringent culture medium containing only insulin, transferrin, and LIF as protein ingredients [Yamane et al., 2005]. In the absence of an adhesive environment such as the surface of culture dishes coated with cell matrix proteins, we found that the ES cell strains tested (D3, E14, and EB5) continued to proliferate under these stringent culture conditions. Soon after the transfer of ES cells prepared under standard adhesive culture conditions with serum to this stringent, suspension culture condition, the cells started to stick to each other and formed cell “clumps” (Fig. 1A-D
We found PVA to be an important ingredient for the ES-cell suspension cultures. PVA is a synthetic resin formed by saponification of polyvinyl acetate and used as a replacement for serum or albumin. When cells clumps cultured in suspension were transferred to PVA-free medium, single cells detached from the clumps and became attached to the surface of the non-coated dish, as shown in Fig. 1F Next we tested whether the suspension culture method would allow clonal proliferation of ES cells. Cells separated from a suspension culture passaged 30 times were seeded onto 96-well plates, 1 cell per well containing 100μl medium, by using a cell sorter. In this condition, after observing 500 wells, we never found a single cell clump; and these single cells did not even divide once. When 50 cells were inoculated per well for suspension cultures, again no cell clumps were seen, whereas in this case, 100% of the cells transferred to adhesion cultures formed colonies. By increasing the density of suspension cultures to 500 cells per well, proliferating cell clumps were detected in 90±11 % of the wells. Obviously, the suspension culture condition did not support the clonal expansion of ES cells. While ACTH supported the clonal expansion of undifferentiated ES cells in adhesion culture [Niwa et al., 2000], we could not detect the expansion of the suspension culture started from a single cell by adding 10 μM ACTH (data not shown). It should be noted, however, that suspension-cultured ES cells retained a clonal proliferation capability under the standard (adhesion) growth condition, even after long-term culturing in suspension as described in the next section. Since relatively large spheric cell clumps are formed in suspension culture, proliferative disadvantages such as a lack of nutrients may affect the viability of the cells inside of the spheric cell masses. However, we did not observe dead cells inside of them after trypan blue staining. Histological section of the spheric cells masses revealed uniformly distributed, round cells without heterogeneous morphology (Fig.1J Undifferentiated state of the ES cells was maintained in suspension cultures Cells that were cultured in the suspended state were confirmed to be undifferentiated by their expression of alkaline phosphatase (ALP) and gene expression pattern. For both D3 (Fig.2A
The undifferentiated state of suspension-cultured ES cells was verified by the expression of Oct3/4 [Niwa et al., 2000; Masui et al., 2007], Nanog [Mitsui K et al., 2003; Chambers et al., 2003], Eras [Takahashi et al., 2003], and Rex1/Zfp42 [Ben-Shushan et al., 1998] genes, all known to be important for the maintenance of the undifferentiated state of ES cells (Fig. 2E Using DNA microarray analysis, we further confirmed the expression level of genes usually highly expressed in undifferentiated ES cells, such as those listed in Fig. 2G Suspension-cultured ES cells are pluripotent for in vitro and in vivo differentiation To confirm the differentiation potential, we dissociated suspension-cultured cells passaged more than 30 times and cultured them under the conditions necessary to induce melanocyte differentiation [Yamane et al.,1999;Kunisada et al.,2003]. After 14 days, melanocytes appeared in the cultures (Fig. 3A, B
To demonstrate their pluripotency in vivo, we injected cells passaged more than 30 times passaged in suspension culture into blastocysts, which were then transferred into the uterus of pseudopregnant ICR females. E 11.5 embryos obtained showed chimerism in most of their tissues, as shown by the abundant GFP-positive cells derived from GFP-expressing D3 strain [Hirano et al.,2003](Fig.3E ES cells in suspension were induced to express genes related to cell adhesion To elucidate the molecular basis enabling the suspension culture of ES cells, we compared gene expression patterns of the cells under both culture conditions by DNA microarray analysis. Under the suspension culture condition, 136 genes were found to be up-regulated more than 5-fold compared with those under the adhesion culture condition. Likewise, 29 genes were down-regulated in suspension culture (Fig. 4A
DISCUSSION In this study, we showed that our suspension cultures, which did not require serum or animal-derived product including extracellular matrix proteins to coat the surface of the culture dish, could maintain mouse ES cells for both proliferation and pluripotency. Although we routinely used LIF produced by CHO cells (culture supernatant, added to 0.1 % of the medium), ESGRO (commercially available purified LIF protein; Chemicon International) was also tested and found to be able to maintain ES cells (data not shown). The only animal-derived components used presently were insulin, transferrin, and LIF. The use of the least amount of animal-derived products may well contribute to eliminate the risk of immunogenicity and transmission of viruses by future therapeutic use of ES cell derivatives. Aggregated growth of undifferentiated mouse ES cells was performed by using spinner culture flask-based bioreactor systems [Cormier et al.,2006; Fok et al.,2005]. In these reported suspension cultures, medium containing 15% fetal bovine serum were used and continuous mechanical shear control were necessary to maintain cell proliferation. Recent progress has been made in studies using human ES cells, in which these cells could be successfully maintained in a proliferative and pluripotent state even when the feeder cells and serum were replaced with mostly defined proteins or chemicals [Ludwig et al., 2006; Sato et al., 2004; Xu et al., 2001; Xu et al., 2005; Lu et al., 2006; Pyle et al., 2006; Darr et al., 2006]. However, all of these reported human ES cell cultures used matrix protein-coated dishes and multiple recombinant proteins in addition to a considerable amount of human serum-derived albumin. We adopted the same suspension culture condition described here for human ES cells but it was not successful at present, possibly indicating the different origin of human ES cells from mouse ES cells [Brons et al., 2007]. In any case, the application of our suspension culture system to human ES cells would drastically reduce the amount of animal-derived product and thus might contribute to future application of ES cells to regenerative cell therapy and tissue engineering. According to the results of the RT-PCR and microarray analysis, the gene networks responsible for the undifferentiated state of ES cells were functional under either culture condition (Fig. 2 We noticed that over 100 genes related to neural differentiation (e.g., Dbx1, Dcx, Efnb3, Astn1, Robo3, Pou3f2) were more highly expressed in the suspension cell culture than in the attached cell cultures in the microarray data. However, we did not observe neuron-like cells in the cultures at 48 hours after the initiation of differentiation from the suspension cultured ES cells, therefore, is not likely that ES cells maintained in suspension culture is neural stem cell-like populations. Still, considering the fact that stem cells potentially differentiate into neural cells have a tendency to form spheres or cell masses under stringent growth conditions without serum, roles of selectively expressed neural differentiation genes should further be investigated. The pluripotency of the ES cells was also confirmed in spite of the apparent morphological difference between suspension- and adhesive-culture conditions. Therefore, the inalienable association of the undifferentiated state of the ES cells with their pluripotency might not necessarily be related to a specific cell culture method or cellular morphology. In summary, a novel function of PVA to stimulate sphere-forming suspension culture of ES cells was elucidated in this study. Our novel suspension culture method facilitates the long-term proliferation of pluripotent ES cells without feeder cells. Low-cost maintenance of the culture using the least amount of synthetic or animal-derived peptidic products is a merit of the present culture system in terms of potential use for future therapeutic application. Although the same suspension culture condition is not sufficient to maintain human ES cells, low-cost and animal-derived product free culture system must be developed to facilitate human ES cell-based cell therapy. EXPERIMENTAL PROCEDURES Cell culture Maintenance of mouse ES cell line For conventional adherent cultures, EGFP D3, EB5, and E14 ES cell lines were maintained on mouse embryonic fibroblasts (MEFs) seeded in gelatin-coated plates in Dulbecco’s minimal essential medium (GIBCO) supplemented with 15 % FCS, 2 mM L-glutamine (GIBCO), 0.1 mM 2-mercaptoethanol (Sigma), 1x non-essential amino acids (GIBCO), 1 mM sodium pyruvate (Invitrogen), 1000 units/ml LIF (culture supernatant of CHO cells expressing LIF or ESGRO [GIBCO]), 100 units/ml penicillin (GIBCO), and 100 μg/ml streptomycin (GIBCO). The medium was changed daily, and the culture was passaged every 2-3 days onto MEFs. For suspension cultures, ES cells prepared from conventional adherent cultures by trypsinization were washed with PBS and transferred to bacterial grade non-coated dishes containing Iscove’s modified Dulbecco medium/F12 (1:1) (GIBCO), supplemented with 2 mM L-glutamine (GIBCO), 0.1 mM 2-mercaptoethanol (Sigma), 0.1 % polyvinyl alcohol (PVA, Sigma), 1x insulin-transferin-selenium-X (GIBCO), 1000 units/ml LIF (CIBCO or culture supernatant), 100 units/ml penicillin (GIBCO), and 100 μg/ml streptomycin (GIBCO). PVA concentrated solution was prepared by adding 10% (w/v) of PVA to D2W and dissolving it by constant stirring for 24 h at 60°C. When indicated, 10μm ACTH (R &D) was added. Starting from a mostly single cell suspension of ES cells in the medium, the cells spontaneously form small aggregates after 12 hours. These small cell masses then aggregate to form larger cell masses. The cells are likely to proliferate constantly during this process. Half of the medium was exchanged for fresh medium every day. Cells were split 1:2 for passaging after mechanical dissociation by pipetting every 3-4 days. Induction of melanocyte differentiation To induce melanocyte differentiation in vitro, we dissociated ES cells and seeded them at 1000-2000 cells/well in 6-well plates pre-seeded with ST2 stromal cell line. They were cultured in α-minimum essential medium (GIBCO) supplemented with 5% calf serum, 10 mM dexamethasone, 200 nM basic FGF, and 50 nM cholera toxin, as previously described [Yamane et al.,1999; Kunisada et al.,2003]. Assay for alkaline phosphatase activity and histological analysis Cells were washed twice with PBS, and then fixed with 4 % paraformaldehyde at room temperature for 4 minutes. Fresh naphthol AS-MX phosphatase solution (0.6 g/l) containing fast red violet B salt (0.1 g/l) in 100 mM Tris-HCl (pH 8) and 50 mM MgCl2 was then added, and incubation was carried out for 30 min at room temperature. Under these conditions, alkaline phosphatase-positive cells were stained pink or red. For histological analysis, cell clumps gently isolated from the suspension culture were fixed by immersion in 10% formalin in phosphate buffer (PH 7.2) for 30 min, dehydrated with ethanol and xylene, and embedded in paraffin. Serial sections of 3-μm thickness were prepared and stained with hematoxylin and eosin. Flow-cytometric analysis Cells were dissociated and incubated in primary antibody against SSEA-1(diluted 1:1000 in PBS containing 5%FCS; Developmental Studies Hybridoma Bank) for 10 min at 4°C, and washed in PBS containing 5%FCS. APC conjugated anti-IgM antibody was then incubated (diluted 1:1000 in PBS containing 5%FCS; Pharmingen) for 10 min at 4°C. Negative controls were treated identically without primary antibody. RNA extraction and RT-PCR RNA was extracted by using Isogen (Wako) according to the manufacturer’s instructions. First-strand cDNA was prepared by using Super Script reverse transcriptase (Invitrogen) primed with random hexamer in a 20-μl reaction mixture containing 5 μg of total RNA. A total of 0.5 μl of the first-strand cDNA mixture was used for PCR with Taq polymerase (TAKARA) performed in a 50-μl volume. The following conditions were used: 10 min at 95 °C followed by 40 cycles of 15 seconds at 95 °C and 1 min at 60 °C (for Oct4, Nanog, ERas, Rex-1, Snail1, Gata4, Slug, and Gapdh) or 2 min at 94 °C followed by 25 cycles of 30 seconds at 94 °C, 30 seconds at 56 °C, and 1 min at 72 °C (for Itgb8, Cdh11, and Col3a1). The PCR reaction products were separated by gel electrophoresis, and the DNA bands were visualized under ultraviolet light for photography. The primer sequences (shown as forward followed by reverse) used were the following: GGCGTTCTCTTTGGAAAGGTGTTC and CTCGAACCACATCCTTCTCT for Oct4; TCTGGGAACGCCTCATCAAT and GGAGAGGCAGCCTCTGTGC for Nanog; GCTGGGGAATGGCTTTGCCTA and CAAAGATCTTCAGGCTACAG for ERas; GCGACATTTTCTGGTGCACA and CTTTCCTGTTGGAACTATGCC for Rex-1; ATAGCGAGCTGCAGGACGCGTGTGT and AGGCCGAGGTGGACGAGAAGGACGA for Snail1; GCCTGTATGTAATGCCTGCG and CCGACGAGGAATTTGAAGAGG for Gata4; AAGGCTTTCTCCAGACCCTGGCTG and CAGCCAGATCCTCATGTTTATGC for Slug; CTGAAGAAATACCCCGTGGA and CATGGGGAGGCATACAGTCT for Itgb8; CACAGGATGGTGTGGTGAAG and AGGCTCATCGGCATCTTCTA for Cdh11; TTGATGTGCAGCTGGCATTC and GCCACTGGCCTGATCCATAT for Col3a1; and CTTCACCACCATGGAGAAGGC and GGCATGGACTGTGGTCATGAG for Gapdh. Clonal proliferation analysis To test the potential for clonal proliferation, we dissociated suspension-cultured ES cells into single-cell suspensions by trypsin-EDTA treatment (37°C, 5min), and then seeded 1 or 50 cells per well into a 96-well plate or 500, 1000 or 5000 cells per well into a 24-well plate. The medium was changed every-2 days until a visible spheric cell mass appeared. For comparison, cells were also cultured under the conventional adhesion condition. Production of chimeric mice Blastocysts were collected from superovulated BDF1×BDF1 females at embryonic day 3.5, injected with ES cells, and then transferred into the uterus of embryonic day-2.5 pseudopregnant ICR females. The EGFP-expressing D3 ES cell line was used for the identification of ES cell-derived cell lineages. DNA microarray analysis DNA microarray analysis was performed as described [Carter et al.,2005]. Data were analyzed by using the NIA Array Analysis tool [Sharov et al.,2005] (http://lgsun.grc.nia.nih.gov/ANOVA/) and DAVID (http://david.abcc.ncifcrf.gov/) software. The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number GSE9022. (The link for reviewers: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=jrqxxicaycecone&acc=GSE9022). Supp 1 Click here to view.(194K, doc) ACKOWLEDGEMENT We thank Dr. Yasuhiro Yamada for help in producing the chimeric mice and Dr. Yulan Piao for performing the microarray work and Dr. Kenichi Tezuka for discussion. We also thank Dr. Hitoshi Niwa for providing EB5 ES cell line and critical reading of the manuscript and valuable advices. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported in part by the Intramural Research Program of National Institute on Aging, NIH. We thank Dr. Hitoshi Niwa for providing EB5 ES cell line. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Intramural Research Program of National Institute on Aging, NIH. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Annu Rev Cell Dev Biol. 2001; 17():435-62.
[Annu Rev Cell Dev Biol. 2001]Nature. 1981 Jul 9; 292(5819):154-6.
[Nature. 1981]Proc Natl Acad Sci U S A. 1981 Dec; 78(12):7634-8.
[Proc Natl Acad Sci U S A. 1981]Nature. 2001 Nov 1; 414(6859):92-7.
[Nature. 2001]Anat Histol Embryol. 2002 Jun; 31(3):169-86.
[Anat Histol Embryol. 2002]Genes Dev. 1998 Jul 1; 12(13):2048-60.
[Genes Dev. 1998]EMBO J. 1999 Aug 2; 18(15):4261-9.
[EMBO J. 1999]Proc Natl Acad Sci U S A. 1999 Mar 16; 96(6):2846-51.
[Proc Natl Acad Sci U S A. 1999]Cell. 2003 Oct 31; 115(3):281-92.
[Cell. 2003]J Cell Sci. 2007 Jan 1; 120(Pt 1):55-65.
[J Cell Sci. 2007]Lab Invest. 2002 Dec; 82(12):1765-7.
[Lab Invest. 2002]Proc Natl Acad Sci U S A. 2005 Mar 1; 102(9):3312-7.
[Proc Natl Acad Sci U S A. 2005]Nat Biotechnol. 2006 Feb; 24(2):185-7.
[Nat Biotechnol. 2006]Proc Natl Acad Sci U S A. 2005 Mar 1; 102(9):3312-7.
[Proc Natl Acad Sci U S A. 2005]Proc Natl Acad Sci U S A. 2005 Mar 1; 102(9):3312-7.
[Proc Natl Acad Sci U S A. 2005]Nat Genet. 2000 Apr; 24(4):328-30.
[Nat Genet. 2000]Nat Genet. 2000 Apr; 24(4):328-30.
[Nat Genet. 2000]Nat Cell Biol. 2007 Jun; 9(6):625-35.
[Nat Cell Biol. 2007]Cell. 2003 May 30; 113(5):631-42.
[Cell. 2003]Cell. 2003 May 30; 113(5):643-55.
[Cell. 2003]Nature. 2003 May 29; 423(6939):541-5.
[Nature. 2003]Dev Dyn. 1999 Dec; 216(4-5):450-8.
[Dev Dyn. 1999]Methods Enzymol. 2003; 365():341-9.
[Methods Enzymol. 2003]Dev Dyn. 2003 Dec; 228(4):664-71.
[Dev Dyn. 2003]Tissue Eng. 2006 Nov; 12(11):3233-45.
[Tissue Eng. 2006]Stem Cells. 2005 Oct; 23(9):1333-42.
[Stem Cells. 2005]Nat Biotechnol. 2006 Feb; 24(2):185-7.
[Nat Biotechnol. 2006]Nat Med. 2004 Jan; 10(1):55-63.
[Nat Med. 2004]Nat Biotechnol. 2001 Oct; 19(10):971-4.
[Nat Biotechnol. 2001]Dev Dyn. 1999 Dec; 216(4-5):450-8.
[Dev Dyn. 1999]Methods Enzymol. 2003; 365():341-9.
[Methods Enzymol. 2003]Genome Biol. 2005; 6(7):R61.
[Genome Biol. 2005]Bioinformatics. 2005 May 15; 21(10):2548-9.
[Bioinformatics. 2005]Dev Dyn. 1999 Dec; 216(4-5):450-8.
[Dev Dyn. 1999]